NDC 60575-515

CODAR D

Codeine Phosphate, Pseudoephedrine Hydrochloride

CODAR D is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Respa Pharmaceuticals. The primary component is Codeine Phosphate; Pseudoephedrine Hydrochloride.

• Product ID: 60575-515_076f7810-5c2b-4d9b-9a69-4308cb9440ca
• NDC: 60575-515
• Product Type: Human Otc Drug
• Proprietary Name: CODAR D
• Generic Name: Codeine Phosphate, Pseudoephedrine Hydrochloride
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2011-07-13
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: Respa Pharmaceuticals
• Substance Name: CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE
• Active Ingredient Strength: 8 mg/5mL; mg/5mL
• DEA Schedule: CV
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 60575-515-16

473 mL in 1 BOTTLE (60575-515-16)

• Marketing Start Date: 2011-07-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 60575-515-16 [60575051516]

CODAR D LIQUID

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Billing Unit: ML
• Marketing Start Date: 2011-07-13
• Inactivation Date: 2019-10-29

Drug Details

Active Ingredients

Ingredient	Strength
CODEINE PHOSPHATE	8 mg/5mL

OpenFDA Data

• SPL SET ID: ed5fe2aa-a6cd-4607-834f-c08593b05792
• Manufacturer:
  • Respa Pharmaceuticals
• UNII:
  • GSL05Y1MN6
  • 6V9V2RYJ8N
• RxNorm Concept Unique ID - RxCUI:
  • 1145972
  • 1114878